Albany, NY -- (SBWire) -- 12/07/2017 --A new report added to the repository of Market Research Reports Search Engine "Sexually Transmitted Diseases (STDs) Drug Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025" is a comprehensive repository of information, providing market share, size, and forecast.
Request for Sample Report @ https://www.mrrse.com/sample/3950
Global Sexually Transmitted Diseases (STDs) Drugs: Overview
Sexually transmitted diseases (STDs), also referred as venereal diseases are infections that can pass from person to person during sex. These diseases are caused mainly due to bacteria, viruses, and / or parasites. Sexually transmitted diseases (STDs) often go undiagnosed because these infections usually do not exhibit visual symptoms. Chlamydia is a common sexually transmitted disease. It is caused by bacteria called Chlamydia trachomatis. It can infect both men and women. Gonorrhea is caused due to bacterial infection (bacterium Neisseria gonorrhoeae) that can be passed from one person to another during sex. The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss of ability to fight against the organism that causes disease.
Global Sexually Transmitted Diseases (STDs) Drugs: Trends and Opportunities
The global market for sexually transmitted diseases (STDs) drug is expanding significantly, owing to increased chances of infection led by increase in the life expectancy of people across the globe. Rise in incidences of unprotected sex has led to an increase in the prevalence of sexually transmitted diseases. A driving factor for the sexually transmitted diseases (STDs) drug is rising initiatives by governments and multiple agencies drawn up guidelines or recommendations for sexually transmitted diseases (STDs). Low voluntary screening rate for sexually transmitted diseases (STDs) is major restrain for this market.
Global Sexually Transmitted Diseases (STDs) Drugs: Segmentation
The global sexually transmitted diseases (STDs) drug market has been segmented on the basis of disease type, therapy class, distribution channel, and region. On the bases of disease type, sexually transmitted diseases (STDs) drug market can be further segmented into chlamydia, gonorrhea, syphilis, human papillomavirus infection, HIV/AIDS and others. According to therapy class sexually transmitted diseases (STDs) drug market can be segmented into antibiotics, antiviral, vaccines and others. Antiviral drugs are used in the treatment of lethal viral infections caused by viruses like human immunodeficiency virus (HIV), hepatitis, influenza A and B viruses and herpes viruses. Vaccination has been promoted as a vital public health intervention across the globe for decades. According to the World Health Organization (WHO), vaccination has reduced the global burden of infectious disease to a great extent. In terms of distribution channel, the sexually transmitted diseases (STDs) drug market can be segmented into hospitals pharmacies, retail pharmacies, online pharmacies and others. In terms of revenue, the hospitals segment held a significant share of the sexually transmitted diseases (STDs) drug market in 2016.
Global Sexually Transmitted Diseases (STDs) Drugs: Regional Outlook
Geographically, the global sexually transmitted diseases drug market is segmented into five regions: North America, Europe, Asia Pacific, Latin America and Middle East & Africa. These regions have been further segmented by countries, disease type, and therapy class and distribution channel. North America dominated the market and is anticipated to gain more market share by the end of 2025. The competition matrix section included in the report is likely to assist the existing players to increase their market shares and new companies to establish their presence in the global sexually transmitted diseases (STDs) drug market.
Companies Mentioned in Report
The report also profiles major players in the market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Major companies competing in the global sexually transmitted diseases drug market, and profiled in the report include Pfizer INC, Hoffmann La Roche, Bayer Healthcare, Eli Lilly, Johnson & Johnson, Bristol-Myers Squibb Co. AbbVie, Inc., Gilead Sciences, GlaxoSmithKline Plc, and Merck & Co., Inc.
Browse Complete Report with TOC @ https://www.mrrse.com/sexually-transmitted-disease-drugs-market
Sexually Transmitted Diseases (STDs) Drug Market is segmented as below:
Sexually Transmitted Diseases (STDs) Drug Market, by Disease Type
Chlamydia
Gonorrhea
Syphilis
Genital herpes
HPV
HIV/AIDS
Others
Sexually Transmitted Diseases (STDs) Drug Market, by Therapy Class
Antibiotics
Antiviral/Antiretrovirals
Vaccines
Others
Sexually Transmitted Diseases (STDs) Drug Market, by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Sexually Transmitted Diseases (STDs) Drug Market, by Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Send an Enquiry @ https://www.mrrse.com/enquiry/3950
About Market Research Reports Search Engine (MRRSE)
Market Research Reports Search Engine (MRRSE) is an industry-leading database of Market Research Reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.
MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE's repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.
Contact Us
State Tower
90, State Street
Suite 700
Albany, NY - 12207
United States Telephone: +1-518-730-0559
Email: sales@mrrse.com
Website: https://www.mrrse.com/
Read More Industry News At: https://www.industrynewsanalysis.com/
Sexually Transmitted Diseases Testing Market Is Expected to Garner $167.4 Bn by 2020
STD Testing Market (Sexually Transmitted Diseases Testing Market) is expected to garner $167.4 billion by 2020, registering a CAGR of 8.5% during the forecast period 2014-2020